STRS Ohio’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

STRS Ohio’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-28,300	Closed	-$445K	–	2200
2018 Q2	$476K	Sell	28,300 -3,300	-10%	-$64.1K	﹤0.01%	1394
2018 Q1	$723K	Buy	31,600 +3,600	+13%	+$80.1K	﹤0.01%	1095
2017 Q4	$724K	Buy	+28,000	New	+$564K	﹤0.01%	1085

Other funds holding CNCE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

STRS Ohio's CNCE Position: Q3 2018 in Review

STRS Ohio sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q3 2018, closing a stake of 28,300 shares — an estimated $445K sold.

STRS Ohio first reported a position in CNCE in Q4 2017 and held it in 3 quarters. The position peaked at $724K in Q4 2017. 111 funds tracked by Wall St. Rank hold CNCE as of Q3 2018.

STRS Ohio reported no remaining Concert Pharmaceuticals, Inc. position as of Q3 2018 after selling out during the quarter.
STRS Ohio sold 28,300 Concert Pharmaceuticals, Inc. shares in Q3 2018, an estimated $445K.
STRS Ohio first reported a position in Concert Pharmaceuticals, Inc. in Q4 2017 and held it in 3 quarters.
STRS Ohio's Concert Pharmaceuticals, Inc. position peaked at $724K in Q4 2017.
111 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q3 2018.

Based on STRS Ohio's 13F filing for Q3 2018, filed 19 Oct 2018.